Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1984 Feb;76(2):184-186, 189.

Waldenström's Macroglobulinemia: Report of a Case With Pulmonary Involvement and Recurrent Pneumococcal Sepsis After Pneumococcal Vaccination

Talmadge E King, Marvin I Schwarz, Mary Mathew
PMCID: PMC2561739  PMID: 6423829

Abstract

A patient with Waldenström's macroglobulinemia who presented with pleuropulmonary manifestations is described. The course was complicated by recurrent Streptococcus pneumoniae infections despite pneumococcal immunization.

Full text

PDF
184

Images in this article

185Figure 1
on p.185
186Figure 2
on p.186

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borgoño J. M., McLean A. A., Vella P. P., Woodhour A. F., Canepa I., Davidson W. L., Hilleman M. R. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc Soc Exp Biol Med. 1978 Jan;157(1):148–154. doi: 10.3181/00379727-157-40010. [DOI] [PubMed] [Google Scholar]
  2. Broome C. V. Efficacy of pneumococcal polysaccharide vaccines. Rev Infect Dis. 1981 Mar-Apr;3 (Suppl):S82–S96. doi: 10.1093/clinids/3.supplement_1.s82. [DOI] [PubMed] [Google Scholar]
  3. Broome C. V., Facklam R. R., Fraser D. W. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med. 1980 Sep 4;303(10):549–552. doi: 10.1056/NEJM198009043031003. [DOI] [PubMed] [Google Scholar]
  4. FAHEY J. L., SCOGGINS R., UTZ J. P., SZWED C. F. INFECTION, ANTIBODY RESPONSE AND GAMMA GLOBULIN COMPONENTS IN MULTIPLE MYELOMA AND MACROGLOBULINEMIA. Am J Med. 1963 Nov;35:698–707. doi: 10.1016/0002-9343(63)90140-2. [DOI] [PubMed] [Google Scholar]
  5. GLENCHUR H., ZINNEMAN H. H., HALL W. H. A review of fifty-one cases of multiple myeloma; emphasis on pneumonia and other infections as complications. AMA Arch Intern Med. 1959 Feb;103(2):173–183. doi: 10.1001/archinte.1959.00270020001001. [DOI] [PubMed] [Google Scholar]
  6. Hirschmann J. V., Lipsky B. A. Pneumococcal vaccine in the United States. A critical analysis. JAMA. 1981 Sep 25;246(13):1428–1432. [PubMed] [Google Scholar]
  7. IMHOF J. W., BAARS H., VERLOOP M. C. Clinical and haematological aspects of macroglobulinaemia Waldenström. Acta Med Scand. 1959 Apr 15;163(5):349–366. doi: 10.1111/j.0954-6820.1959.tb10414.x. [DOI] [PubMed] [Google Scholar]
  8. Landesman S. H., Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis. 1981 Mar-Apr;3 (Suppl):S184–S197. doi: 10.1093/clinids/3.supplement_1.s184. [DOI] [PubMed] [Google Scholar]
  9. Lazarus H. M., Lederman M., Lubin A., Herzig R. H., Schiffman G., Jones P., Wine A., Rodman H. M. Pneumococcal vaccination: the response of patients with multiple myeloma. Am J Med. 1980 Sep;69(3):419–423. doi: 10.1016/0002-9343(80)90014-5. [DOI] [PubMed] [Google Scholar]
  10. MacKenzie M. R., Fudenberg H. H. Macroglobulinemia: an analysis for forty patients. Blood. 1972 Jun;39(6):874–889. [PubMed] [Google Scholar]
  11. Rausch P. G., Herion J. C. Pulmonary manifestations of Waldenstrom macroglobulinemia. Am J Hematol. 1980;9(2):201–209. doi: 10.1002/ajh.2830090208. [DOI] [PubMed] [Google Scholar]
  12. Wakim K. G. Reassessment of the source, mode and locus of action of antidiuretic hormone. Am J Med. 1967 Mar;42(3):394–411. doi: 10.1016/0002-9343(67)90268-9. [DOI] [PubMed] [Google Scholar]
  13. Winterbauer R. H., Riggins R. C., Griesman F. A., Bauermeister D. E. Pleuropulmonary manifestations of Waldenstrom's macroglobulinemia. Chest. 1974 Oct;66(4):368–375. doi: 10.1378/chest.66.4.368. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES